Qiagen N.V. SEC filings QGEN
Qiagen N.V. has 512 filings in SEC EDGAR's recent list, going back to Oct 6, 1998. Its latest annual report, Form 20-F, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 6, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Mar 20, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2025 | Dec 31, 2024 |
| 20-F | Annual report (foreign issuer) | Mar 11, 2024 | Dec 31, 2023 |
| 20-F | Annual report (foreign issuer) | Mar 13, 2023 | Dec 31, 2022 |
| 20-F | Annual report (foreign issuer) | Mar 14, 2022 | Dec 31, 2021 |
| 20-F | Annual report (foreign issuer) | Mar 5, 2021 | Dec 31, 2020 |
| 20-F | Annual report (foreign issuer) | Mar 2, 2020 | Dec 31, 2019 |
| 20-F | Annual report (foreign issuer) | Mar 6, 2019 | Dec 31, 2018 |
| 20-F | Annual report (foreign issuer) | Mar 6, 2018 | Dec 31, 2017 |
| 20-F | Annual report (foreign issuer) | Mar 6, 2017 | Dec 31, 2016 |
| 20-F | Annual report (foreign issuer) | Feb 29, 2016 | Dec 31, 2015 |
| 20-F | Annual report (foreign issuer) | Mar 2, 2015 | Dec 31, 2014 |
| 20-F | Annual report (foreign issuer) | Mar 3, 2014 | Dec 31, 2013 |
| 20-F | Annual report (foreign issuer) | Mar 4, 2013 | Dec 31, 2012 |
| 20-F | Annual report (foreign issuer) | Mar 27, 2012 | Dec 31, 2011 |
| 20-F | Annual report (foreign issuer) | Mar 21, 2011 | Dec 31, 2010 |
| 20-F | Annual report (foreign issuer) | Mar 17, 2010 | Dec 31, 2009 |
| 20-F | Annual report (foreign issuer) | Mar 25, 2009 | Dec 31, 2008 |
| 20-F | Annual report (foreign issuer) | Mar 20, 2008 | Dec 31, 2007 |
| 20-F | Annual report (foreign issuer) | Apr 2, 2007 | Dec 31, 2006 |
| 20-F | Annual report (foreign issuer) | Apr 3, 2006 | Dec 31, 2005 |
| 20-F | Annual report (foreign issuer) | Apr 19, 2005 | Dec 31, 2004 |
| 20-F | Annual report (foreign issuer) | Mar 26, 2004 | Dec 31, 2003 |
| 20-F | Annual report (foreign issuer) | Mar 31, 2003 | Dec 31, 2002 |
| 20-F | Annual report (foreign issuer) | Apr 2, 2002 | Dec 31, 2001 |
Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- QGEN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Netherlands
- Headquarters
- Pl Venlo
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1015820
- Former names
- QIAGEN NV (until Feb 14, 2020)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.